Infectious
Conditions
Keywords
Covid-19, characteristics, Outcome, Egypt
Brief summary
Patients confirmed COVID-19 with gastrointestinal manifestations will be included. Characteristics and outcomes will be described for them.
Detailed description
Patients diagnosed as confirmed Covid-19 according to WHO and Egyptian Ministry of Health and Population (MOH) definitions will be included.The following will be done for all patients: Demographic characters; age, sex, presence of co-morbidities such as hypretension, diabetes mellitus, obstructive lung diseases, ischemic heart diseases...etc, history of contact to covid-19 patients or recent travelling abroad.Clinical Characteristics: By recording of clinical manifestation such as fever, cough, shortness of breath, sore throat, change in taste or smell, nausea,vomiting and diarrhea will be done. Complications and the type of treatment received by the patients will also be described including mechanical ventilation. Laboratory data will also be included : blood picture, liver enzymes, ESR,CRP, serum ferritin, D-dimer and troponin. Follow up of the patients will be done until improvement, deaths or complications to determine disease outcomes.
Interventions
Laboratory tests such as CBC, Liver function and CRP
Sponsors
Study design
Eligibility
Inclusion criteria
* Confirmed Covid-19 with GIT manifestations
Exclusion criteria
* Patients refuse to participate
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Clinical data questionnaire | 2 months | Clinical characteristics of age, sex, comorbidities and symptoms. |
| Tests such as CBC | 2 months | Laboratory characters |
| liver function test | 2 months | Laboratory characters |